Skip to main content
All lobbying filings

HOLLAND & KNIGHT LLP

Lobbying for SOUND PHARMACEUTICALS, INC. · Bio-pharmaceutical platform developing novel treatments to prevent and treat hearing loss

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Washington · House · Senate · $60,000.00 income · posted Jul 15, 2026

Official filing document

 Bills named in this filing 3
  • HR 8469
    Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fisca…
  • HR 8646
    Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
  • HR 9495
    Department of Defense Appropriations Act, 2027
 Lobbying activity 4
Defense

Issues related to hearing loss and treatment; H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027.

Veterans

Issues related to hearing loss and treatment; H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027.

Budget/Appropriations

Issues related to hearing loss and treatment; H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027; H.R.9495 - Department of Defense Appropriations Act, 2027.

Medical/Disease Research/Clinical Labs

Issues related to hearing loss and treatment.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem